ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · Real-Time Price · USD

160.89

-6.69 (-3.99%)

At close: Sep 8, 2026, 4:00 PM EDT

160.79

-6.79 (-4.05%)

Pre-market: Sep 9, 2026, 6:53 AM EDT

ICU Medical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,160	2,231	2,382	2,259	2,280	1,316
Revenue Growth	-8.97%	-6.33%	5.44%	-0.92%	73.21%	3.56%
Gross Profit	826.25	822.04	824.78	739.87	697.76	491.49
Operating Income	124.85	109.33	97.41	47.84	-3.57	141.41
Net Income	30.09	0.73	-117.69	-29.66	-74.29	103.14
Earnings Per Share	1.20	0.03	-4.83	-1.23	-3.11	4.74
EPS Growth	-	-	-	-	-	17.91%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Consumables	1,137	1,109	1,039	969.13	974.99	555.19
Infusion Systems	718.81	684.21	652.41	629.04	617.44	352.32
Vital Care	303.47	437.92	690.77	660.95	687.57	408.8
Revenue (Total)	2,160	2,231	2,382	2,259	2,280	1,316

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	302.64	311.71	319.6	278.98	242.77	568.59
Total Debt	1,287	1,353	1,643	1,705	1,735	47.17
Net Cash (Debt)	-984.52	-1,041	-1,323	-1,426	-1,492	521.42
Net Cash Growth	-	-	-	-	-	45.07%
Net Cash Per Share	-39.23	-41.81	-54.25	-59.18	-62.53	23.94

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	236.37	179.85	204.03	166.2	-62.13	267.54
Capital Expenditures	-83.54	-88.04	-79.37	-83.89	-90.31	-68.54
Free Cash Flow	152.83	91.8	124.66	82.31	-152.44	199
Free Cash Flow Growth	152.53%	-26.36%	51.46%	-	-	52.20%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.26%	36.84%	34.63%	32.75%	30.60%	37.34%
Operating Margin	5.78%	4.90%	4.09%	2.12%	-0.16%	10.74%
Pretax Margin	-0.04%	0.14%	-2.77%	-3.47%	-5.02%	9.36%
Profit Margin	1.39%	0.03%	-4.94%	-1.31%	-3.26%	7.83%
FCF Margin	7.08%	4.11%	5.23%	3.64%	-6.69%	15.12%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	133.66	4811.54	-	-	-	48.88
Forward PE	52.24	178.72	33.92	33.92	33.92	47.09
P/FCF Ratio	26.33	38.37	30.48	29.25	-	25.33
PS Ratio	1.86	1.58	1.60	1.07	1.66	3.83